Shanghai Fosun Pharmaceutical (Group) Co Ltd 2020 SR
The report highlights Fosun Pharma's 2020 sustainability efforts, focusing on its response to the COVID-19 pandemic through medical supply allocation and mRNA vaccine development with BioNTech. It details significant R&D achievements, including the launch of three biosimilars and the inclusion of Su Ke Xin in the national medical insurance list. The company reduced greenhouse gas emissions by 7,399 tons and achieved a 22.9% decline in carbon emission intensity. Socially, it invested nearly RMB 11 million in targeted poverty alleviation and donated over RMB 40 million to society. The report also emphasizes quality management through the FOPEX system and adherence to international quality standards.
Company: Shanghai Fosun Pharmaceutical (Group) Co Ltd
Sector: Manufacturing
Country: China
Year: 2020
Type: SR
Pages: 142
Back to company
Shanghai Fosun Pharmaceutical (Group) Co Ltd
Corporate Social Responsibility Report
The report highlights Fosun Pharma's 2020 sustainability efforts, focusing on its response to the COVID-19 pandemic through medical supply allocation and mRNA vaccine development with BioNTech. It details significant R&D achievements, including the launch of three biosimilars and the inclusion of Su Ke Xin in the national medical insurance list. The company reduced greenhouse gas emissions by 7,399 tons and achieved a 22.9% decline in carbon emission intensity. Socially, it invested nearly RMB 11 million in targeted poverty alleviation and donated over RMB 40 million to society. The report also emphasizes quality management through the FOPEX system and adherence to international quality standards.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Jan 1, 2020 - Dec 31, 2020
Fiscal Year
2020
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Workplace Fatalities
Employees